CAS number
CAS 83918-57-4 imazalil sulphate (ISO) powder
CAS 58594-72-2 · CAS 83918-57-4 · EC 261-351-5 · EC 281-291-3 · Index No 613-043-00-0 · Index No 613-043-01-8
Where CAS 83918-57-4 appears: every table entry that prints it among its identifiers, in the newest version of each act this record holds, and every recorded change to those entries. Many entries name a group of substances and print no number, so absence here is not absence from the law. Not legal advice.
Where it appears now
CLP Annex VI section 3, Index No 613-043-00-0
Last changed in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names · Annex VI on this site
| Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATEs | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
| 613-043-00-0 | imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Wng | H302 H317 H410 | |||
CLP Annex VI section 3, Index No 613-043-01-8
Last changed in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names · Annex VI on this site
| Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors and ATEs | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||
| 613-043-01-8 | imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Wng | H302 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % | ||
CLP Annex VI section 3, table 2, Index No 613-043-00-0
No change to this entry since the first version the record holds, in force 1 December 2010. · Annex VI on this site
| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|
| 613-043-00-0 | imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)24/25-37-46-60-61 |
CLP Annex VI section 3, table 2, Index No 613-043-01-8
No change to this entry since the first version the record holds, in force 1 December 2010. · Annex VI on this site
| Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes |
|---|---|---|---|---|---|---|---|
| 613-043-01-8 | imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Xn; R22 C; R34 R43 N; R50-53 | C; N R: 22-34-43-50/53 S: (2-)26-36/37/39-45-60-61 | C; R34: C ≥ 50 % Xi; R38: 30 % ≤ C < 50 % Xi; R41: 15 % ≤ C < 50 % Xi; R36: 5 % ≤ C < 15 % |
Look up a number
Type a CAS or EC number, with or without its hyphens, or an Index No into the search box at the top of the page: it reads 50000 as CAS 50-00-0. Every number is also listed by act on the substances page.
Its history
· amended · CLP Annex VI section 3, Index No 613-043-00-0
Recorded in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names. Only spacing, dash forms or accents differ. The change on its version page
| Identifiers | Version | Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 613-043-00-0CAS 58594-72-2CAS 83918-57-4EC 261-351-5EC 281-291-3 | Before | 613-043-00-0 | imazalil sulphate (ISO) powder;
| 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Wng | H302 H317 H410 | |||
| After | 613-043-00-0 | imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H317 H400 H410 | GHS07 GHS09 Wng | H302 H317 H410 | ||||
· amended · CLP Annex VI section 3, Index No 613-043-01-8
Recorded in the version in force , by Regulation (EU) 2018/669 and 2 others, the acts that change names. Only spacing, dash forms or accents differ. The change on its version page
| Identifiers | Version | Index No | Chemical name | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s) | ||||||||
| Index No 613-043-01-8CAS 58594-72-2CAS 83918-57-4EC 261-351-5EC 281-291-3 | Before | 613-043-01-8 | imazalil sulphate (ISO), aqueous solution;
| 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Wng | H302 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % | ||
| After | 613-043-01-8 | imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] 281-291-3 [2] | 58594-72-2 [1] 83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 | H302 H314 H317 H400 H410 | GHS05 GHS07 GHS09 Wng | H302 H314 H317 H410 | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % | |||
Sources
- CLP: every version the record holds; rows read from EUR-Lex consolidated version 02008R1272-20270101, in force 1 January 2027 (external, EUR-Lex)